Innovus Pharma Initiates Primate Safety Studies of Its Products That Affect Premature Ejaculation and Penile Sensation

Published: Jul 03, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LA JOLLA, Calif., July 3, 2013 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals Inc., ("Innovus Pharma") (OTCBB:INNV) today announced it started two studies in non-human primates to evaluate the safety of daily use of EjectDelay and CIRCUMserum.

Help employers find you! Check out all the jobs and post your resume.

Back to news